This compound is a metabolite of the kinase inhibitor momelotinib, designated as M19. It is a benzoic acid derivative used as an intermediate in the production of pharmaceutical research materials.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing 4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
4-Ethoxy-3-nitropyridine hydrochloride
pharmaceutical intermediate
3-(Butylamino)-4-(4-hydroxyphenoxy)-5-sulfamoylbenzoic acid
pharmaceutical intermediate
Methyl 2-fluoro-3-nitrobenzoate
pharmaceutical intermediate
Albendazole EP Impurity J
pharmaceutical intermediate
Momelotinib
pharmaceutical raw material
Momelotinib dihydrochloride
pharmaceutical raw material
Momelotinib dihydrochloride monohydrate
pharmaceutical raw material
4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzoic acid
VYXONEXRZMHYRY-UHFFFAOYSA-N
C1COCCN1C2=CC=C(C=C2)NC3=NC=CC(=N3)C4=CC=C(C=C4)C(=O)O
Sourcing 4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzoic acid?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.